13 studies found for:
Lambert-Eaton Myasthenic Syndrome
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
|
||||
| 2 | Recruiting |
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
|
||||
| 3 | Available |
Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
|
||||
| 4 | Unknown † |
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
|
||||
| 5 | Available |
Treatment of Lambert-Eaton Syndrome With 3,4 DAP
|
||||
| 6 | Recruiting |
Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
|
||||
| 7 | Completed |
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
|
||||
| 8 | Available |
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
|
||||
| 9 | Recruiting |
A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
|
||||
| 10 | Available |
Compassionate Use of 3,4-Diaminopyridine
|
||||
| 11 | Recruiting |
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
|
||||
| 12 | Completed |
Pregnancy Outcomes in Congenital Myasthenie Syndrome
|
||||
| 13 | Enrolling by invitation |
Ephedrine for the Treatment of Congenital Myasthenia
|
† Indicates status has not been verified in more than two years